These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36736495)

  • 1. Design, synthesis and biological evaluation of novel tubulin inhibitors targeting colchicine sites.
    Yuan M; Su J; Zhang Y; Qin J; Yang H; Duan Y; Yao Y; Sun M
    Bioorg Med Chem Lett; 2023 Mar; 83():129166. PubMed ID: 36736495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.
    Lai Q; Wang Y; Wang R; Lai W; Tang L; Tao Y; Liu Y; Zhang R; Huang L; Xiang H; Zeng S; Gou L; Chen H; Yao Y; Yang J
    Eur J Med Chem; 2018 Aug; 156():162-179. PubMed ID: 30006162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Design, Synthesis, and Biological Activities of Pyrrole-Based Carboxamides: The Novel Tubulin Inhibitors Targeting the Colchicine-Binding Site.
    Boichuk S; Galembikova A; Syuzov K; Dunaev P; Bikinieva F; Aukhadieva A; Zykova S; Igidov N; Gankova K; Novikova M; Kopnin P
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities.
    Sun YX; Song J; Kong LJ; Sha BB; Tian XY; Liu XJ; Hu T; Chen P; Zhang SY
    Eur J Med Chem; 2022 Feb; 229():114069. PubMed ID: 34971875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site.
    Eissa IH; Dahab MA; Ibrahim MK; Alsaif NA; Alanazi AZ; Eissa SI; Mehany ABM; Beauchemin AM
    Bioorg Chem; 2021 Jul; 112():104965. PubMed ID: 34020238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitors.
    Zhang J; Tan L; Wu C; Li Y; Chen H; Liu Y; Wang Y
    Eur J Med Chem; 2023 Feb; 248():115085. PubMed ID: 36621138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of N-benzylarylamide derivatives as novel tubulin polymerization inhibitors capable of activating the Hippo pathway.
    Song J; Wang SH; Song CH; Zhang WX; Zhu JX; Tian XY; Fu XJ; Xu Y; Jin CY; Zhang SY
    Eur J Med Chem; 2022 Oct; 240():114583. PubMed ID: 35834904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of benz-fused five-membered heterocyclic compounds as tubulin polymerization inhibitors with anticancer activities.
    Komuraiah B; Ren Y; Xue M; Cheng B; Liu J; Liu Y; Chen J
    Chem Biol Drug Des; 2021 May; 97(5):1109-1116. PubMed ID: 33638903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities.
    Li G; Wang Y; Li L; Ren Y; Deng X; Liu J; Wang W; Luo M; Liu S; Chen J
    Eur J Med Chem; 2020 Sep; 202():112519. PubMed ID: 32650183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site.
    Liu YN; Wang JJ; Ji YT; Zhao GD; Tang LQ; Zhang CM; Guo XL; Liu ZP
    J Med Chem; 2016 Jun; 59(11):5341-55. PubMed ID: 27172319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potent tubulin inhibitors targeting the colchicine binding site via structure-based lead optimization and antitumor evaluation.
    Liu W; He Y; Guo Z; Wang M; Han X; Jia H; He J; Miao S; Wang S
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2155815. PubMed ID: 36629423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and bio-evaluation of novel millepachine derivatives targeting tubulin colchicine binding site for treatment of osteosarcoma.
    Geng D; Chen Z; Li Y; Liu T; Wang L
    Bioorg Chem; 2024 Oct; 151():107624. PubMed ID: 39002514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel tubulin inhibitors targeting the colchicine binding site via virtual screening, structural optimization and antitumor evaluation.
    Liu W; Jia H; Guan M; Cui M; Lan Z; He Y; Guo Z; Jiang R; Dong G; Wang S
    Bioorg Chem; 2022 Jan; 118():105486. PubMed ID: 34801948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and optimization of biphenyl derivatives as novel tubulin inhibitors targeting colchicine-binding site overcoming multidrug resistance.
    Cheng B; Zhu G; Meng L; Wu G; Chen Q; Ma S
    Eur J Med Chem; 2022 Jan; 228():113930. PubMed ID: 34794817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of polymethoxyphenyl-pyridines bearing amino side chains as tubulin colchicine-binding site inhibitors.
    Li X; Wu H; Feng KW; Xu J; Wu S; Zhou ZZ; Li XF
    Bioorg Med Chem; 2022 Nov; 73():117007. PubMed ID: 36150341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of novel diphenylamine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site.
    Yan XY; Leng JF; Chen TT; Zhao YJ; Kong LY; Yin Y
    Eur J Med Chem; 2022 Jul; 237():114372. PubMed ID: 35447432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in research of colchicine binding site inhibitors and their interaction modes with tubulin.
    Sun K; Sun Z; Zhao F; Shan G; Meng Q
    Future Med Chem; 2021 May; 13(9):839-858. PubMed ID: 33821673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo.
    Cui YJ; Ma CC; Zhang CM; Tang LQ; Liu ZP
    Eur J Med Chem; 2020 Feb; 187():111968. PubMed ID: 31865012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, modeling, and biological evaluation of anti-tubulin indole-substituted furanones.
    Hurysz B; Evans BA; Laryea RN; Boyer BE; Coburn TE; Dexter MS; Edwards MA; Faulkner GV; Huss RL; Lafferty MM; Manning M; McNulty M; Melvin SJ; Mitrow CM; Patel RR; Pierce K; Russo J; Seminer AM; Sockett KA; Webster NR; Cole KE; Mowery P; Pelkey ET
    Bioorg Med Chem Lett; 2023 Jun; 90():129347. PubMed ID: 37236376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of novel 3-amino-5-phenylpyrazole derivatives as tubulin polymerization inhibitors targeting the colchicine-binding site.
    Yang Y; Cao Y; Yu J; Yu X; Guo Y; Wang F; Ren Q; Li C
    Eur J Med Chem; 2024 Mar; 267():116177. PubMed ID: 38280356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.